Previous investigations of the turnover of normal and "pathological" gamma globulins using radioisotopically in vitro trace-labeled proteins in patients with multiple myeloma, macroglobulineniia, and benign M-type hypergammaglobulinemia (1-10) have yielded different results. The present study was undertaken to delineate and compare simultaneously the metabolism of normal gamma globulin and M-components in nine patients with M-component disease. This has been made possible by the use of a) two radioactive isotopes of iodine to study two proteins at the same time in a single patient and b) a recently developed method of analysis particularly suited to this sort of investigation.
Previous investigations of the turnover of normal and "pathological" gamma globulins using radioisotopically in vitro trace-labeled proteins in patients with multiple myeloma, macroglobulineniia, and benign M-type hypergammaglobulinemia (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) have yielded different results. The present study was undertaken to delineate and compare simultaneously the metabolism of normal gamma globulin and M-components in nine patients with M-component disease. This has been made possible by the use of a) two radioactive isotopes of iodine to study two proteins at the same time in a single patient and b) a recently developed method of analysis particularly suited to this sort of investigation.
MATERIALS AND METHODS
Patients. A summary of the clinical and routine laboratory findings of the nine patients investigated is presented in Table I .
Patient AA died of an Adams-Stokes attack after a short period of paraproteinemic coma about 2 months after the completion of this investigation. Post-mortem examination confirmed the diagnosis of multiple myeloma as well as myeloma renal disease. Patient JS also died several months after being studied, but no postmortem examination was performed.
Exact classification of the M-component disease was clear-cut in most of the patients, but was somewhat uncertain in three patients. Patient ILL is considered to have multiple myeloma rather than benign M-type hypergammaglobulinemia because of the abnormal appearance of her plasma cells and the progressive increase in the serum concentration of M-component during the 9 months she has been observed. Nevertheless, unequivocal osteolytic lesions have not yet been demonstrated. The period of observation of patient GP is thought to be too short to allow one to exclude completely the diagnosis of myeloma, although the evidence to date supports * This work was supported in part by funds from the Swedish Medical Research Council. Protein preparations. Normal 'y-globulin 1 was prepared from the sera of four healthy blood donors fractionated separately. Four of the preparations were produced by ammonium sulfate fractionation followed by chromatography on diethylaminoethyl cellulose (DEAE) with gradient elution (11) from 0.005 M Tris-phosphate, pH 8.0, to 0.3 M Tris-phosphate, pH 7.4. The protein peak eluted with the starting buffer was reprecipitated with ammonium sulfate, dissolved in isotonic saline, and dialyzed against two changes of isotonic saline. One normal 'y-globulin preparation was prepared by first precipitating non-y-globulin material with Rivanol (6,9-diamino-2-ethoxyacridine) (12) and then carrying out further purification as described above.
M-components were purified by the methods outlined by Laurell (13) , which included the techniques already described plus chromatography on carboxymethyl cellulose (CM) using gradient elution from 0.01 M acetate buffer, pH 5.4, to 0.3 M acetate buffer, pH 5.4 (14) .
All operations were carried out at 4 to 100 C.
All protein preparations used in this study were characterized by paper electrophoresis (15) , starch gel electrophoresis (16) , cellulose acetate electrophoresis (17) , and microimmunoelectrophoresis (18) . Antisera for the latter included commercial rabbit antisera against whole human serum and rabbit antisera prepared in this laboratory against purified normal y-globulin and various '81A and -yim M-components. By these criteria all preparations were between 90 and 98% pure. Immunoelectrophoresis revealed one or two non-y-contaminants in six of the preparations, but these were not generally detectable by the other techniques. On starch gel electrophoresis, the two 'ViA-proteins characteristically resolved into multiple bands, and M'YlAILL showed a small amount of a2 1 The following are synonyms for the nomenclature used here: y-globulin = 'yV-globulin, -y,.-globulin, 7S7y-globulin; 'YlA-globulin = y1-globulin, 32A-globulin; 71m-globulin = 19Sy-globulin, gamma macroglobulin, f2m-globulin; -y,, = micromolecular -y-globulin, 'YL (including Bence Jones protein). The term M-component refers to proteins related immunochemically to the above globulins occurring as greatly increased serum or urine concentrations of one or at most a few molecular species. Plasma and urine samples. Heparinized blood samp es of about 5 ml each were collected at frequent intervals during the first 2 days and then every 24 hours for a total of 7 to 25 days. Two ml of plasma from each sample was pipetted into polyethylene counting tubes. All urine was collected in 24-hour portions for from 7 to 14 days, the total volumes were measured, and 2.0-ml sam-nples were pipetted into counting tubes.
Determination of radioactivity. Plasma and urine samples were counted in a well-type scintillation counter coupled to a pulse-height analyzer as in the method of Cohen and Freeman (23) . This technique gave good discrimination between "25 and I"3 radioactivity. The same material used for labeling was used to prepare I 25 and P" standard solutions, which were counted at the same time as the samples. The error of counting was 1% or less at the beginning and 3% or less toward the end of each study.
The amount of radioactivity given to each patient (dose) was determined as I'"' by counting the bottle containing the dose on a lead plate over the well of the counter and recounting the bottle after administration with the washings from the syringe used to inject the labeled proteins. Care was taken to ensure constant geometrical relationships. Counts per minute measured by this arrangement were related empirically to counts measured in the well directly. The I.25 dose was easily calculated from the I"2 radioactivity in the 10-minute plasma sample and the plasma volume calculated from the I.31 radioactivity in the same sample and the known I'" dose. It is assumed that at this time mixing in the plasma compartment was complete and that passage from this compartment owing to either distribution or catabolism was negligible.
Treatment of data. All plasma radioactivities as counts per minute were corrected for background, radioactive METABOLISM OF GAMMA GLOBULINS IN MYELOMA AND ALLIED CONDITIONS decay, and fluctuations in plasma volume. The last was accomplished by dividing the counts per minute by the total protein concentration of the sample, thus obtaining the "total protein-specific activity." I"2 counts per minute were also corrected for contribution from I..1 as described elsewhere (23) . Finally, the plasma "proteinspecific activity" was expressed as a percentage of the 10-minute plasma sample radioactivity and hence as percentage of dose.
Excreted radioactivity per milliliter of urine, corrected for background, decay, and contribution of J131 radioactivity to the P" counting channel, was multiplied by the 24-hour urine volume to obtain total radioactivity excreted per period. whereas the M-component is largely, if not exclusively, degraded in an extravascular pool. A low iodide-excretion rate would tend to produce an extravascular pattern of excretion, but a difference in pattern between two proteins studied in a given patient cannot be ascribed to this cause. Furthermore, iodide excretion has been studied in these patients and was found to be normal. Denatured protein or free label in the injected material would tend to mask the extravascular type of pattern.
More information regarding this question can be obtained by plotting daily excreted radioactivity divided by the corresponding mean daily radioactivity in the plasma, extravascular, and total body compartments (26) . For the compartment where catabolism occurs, the resulting line should be straight and horizontal, especially during the first few days. After equilibration the test no longer applies, since all the quotients will then be constant (i.e., curves for the individual compartments become parallel). This test as applied to the two proteins of GP is seen in Figure 4 . Since the ini- (33) . The labeled protein is introduced into the intravascular compartment (P) where equilibrium takes place with the extravascular space (E) at rates defined by the tracer kinetic constants k1 and k.2. Catabolism occurs potentially from the intravascular compartment at the rate k, and from the extravascular compartment at the rate k4. The label released from catabolism of the labeled protein then enters the degradation products distribution space (I) from which it is excreted at the rate k,. labels in the same way. Hence, there is qualitative evidence that some of the proteins are catabolized extravascularly, at least in part.
FIG. 4. QUOTIENTS OF DAILY EXCRETED
B. The application of Nosslin's method. Nosslin's analysis (29) was applied to the data of the present investigation in a form based on the model shown in Figure 5 . The data are plotted on a linear scale, and first derivatives of the plasma (P) and first and second derivatives of the cumulated urinary (U) curves are determined mechanically (30) . Radioactivity in the degradation products distribution space (I) is determined from k, and the first derivative of U by the relationship dU = k51. In this method, pool ratios are calculated by the following equations: E ki____ Pk2+ k4 [5] and E k± + k3
is based on the assumption of intravascular synthesis, whereas 6 is based on the assumption of extravascular synthesis. Therefore, since it is not known which of these assumptions is correct, E/P is obtained as a range.
When this method was applied to the present data, the plots for determining the kinetic constants were all straight lines ( Figure 6 ) except those of both proteins of OE. Since the plasma curves in this patient required three exponentials for resolution in conventional analysis, it is not surprising that the simple model chosen did not fit the data. In some cases, the early (up to 36 hours) points in the plot for k, and k2 did not fall on a straight line, probably reflecting the fact that there are many extravascular pools which become "lumped" by 48 hours and thereafter behave as a single pool.
Since statistical fitting errors are obtained for the kinetic constants, it is possible to a) determine whether the constants are statistically different from zero and b) compare corresponding constants for both proteins studied in single patients.
The values for kinetic constants with their standard errors, mass turnover data, and pool ratios as calculated by Nosslin's method are given in Table II. Table III gives the statistical comparisons of the paired constants in each patient.
C. Comparison with conventional analyses. To compare these results with those in the literature, the data have also been analyzed by several conventional techniques. For these, plasma radioactivity (Qp), total body or retained radioactivity (QTB, calculated by subtracting the cumulated urinary radioactivity from 100), and extravascular radioactivity (QE, retained minus plasma radioactivity) are plotted on a semilogarithmic scale. Figures 2 and 3 show the plots for two patients, GP and SH.
The results according to the Sterling (31), Matthews (32), Campbell, Cuthbertson, Matthews, and McFarlane (26), and Reeve and Roberts (33) methods are given in Table IV . The fractional catabolic rates as calculated by these methods, in general, differ from each other and from those of Nosslin's analysis, whereas all the mass turnover data are similar no matter which method is used. The Sterling method catabolic rate is based on the final slope of the plasma curve and is thus an apparent degradation rate of the total exchangeable pool after equilibration. Therefore, there is little basis of comparison with Nosslin's k3 and k4. The same reasoning applies to the tj of the final slope of the plasma curve, since this is simply ln 2/degradation rate in the Sterling analysis. The ti's of the final exponentials of each of the plasma curves are given in Table IV . These varied between 7.4 and 28.2 days for all proteins studied, and no consistent differences were noted between those of normal y-globulin and M-components or between those of proteins of different immunoelectrophoretic types.
Matthews' analysis is based on the resolution of (1-6, 8, 10) or as fractions of the plasma pool per day (7) . The tj alone is, in our view and that of others (37, 38) , not a meaningful parameter for comparison without other information, such as is provided by the intercept of the final slope and the slopes and intercepts of the other exponentials that make up the observed and derived curves. Nevertheless, the ti's of IJ13-labeled M-components have been reported as varying between about 7 and 18 days, which is the same range reported for I"3'-labeled y-globulin in normal subjects (39) (40) (41) (42) . In the present study, this same range was observed, although a few ti's were longer than 20 days. The ti's of the two proteins studied in each patient were more similar to each other than were those of similar proteins in different individuals. We did not observe, as has one group (3-6), a longer t4 of normal y-globulin and y-mobility M-components in patients with a ,-mobility M-component compared with those in patients with a y-mobility M-component. In fact, the opposite was the case in our study: in four y patients, normal y-globulin and y-mobility M-components had a mean tj of 19.8 days as compared with a mean to of 8.0 days for normal y-globulin and 8.7 days for 8-mobility M-components in three patients with 8-mobility serum M-components.
Since normal y-globulin in normal subjects is catabolized at the rate of 3 to 8% of the plasma pool per day without extravascular catabolism (23, 43) , the results of the qualitative tests and Nosslin's analysis indicate that the presence of an M-component may in some cases be associated with extravascular catabolism as well. In general, the fractional catabolic rates were the same for both proteins studied in each patient, as seen from Table III , so that the abnormal site and possibly the mode of catabolism affects both proteins. The two exceptions to this were in the case of macroglobulinemia (SH) and one patient with benign M-type hypergammaglobulinemia (GP). The findings in the former patient where y-globulin was catabolized normally but the macroglobulin was catabolized only extravascularly are most interesting. This finding implies a different mode of catabolism for these two proteins. In the two patients with ylA myeloma all proteins were catabolized intravascularly.
Since the intravascular catabolic rates were normal or slightly subnormal in patients where extravascular catabolism occurred, it may be that the superimposition of extravascular catabolism contributes to the observed decrease in normal y-globulin concentration in these patients.
It is tempting to speculate that the extravascular component of catabolism reflects breakdown of y-globulins by malignant plasma cells that may represent a compartment in relatively slow equilibrium with the plasma. This hypothesis was first put forth several years ago (1) . Since different cell types are usually involved in macroglobulinemia than in myeloma, it may be for this reason that normal y-globulin levels are less often disturbed in this condition than in myeloma.
The curious but general finding that y M-components had a higher E/P ratio than normal y-globulin may possibly reflect complex-formation between the pathological proteins and cellular elements of the blood or vascular endothelium not observed with normal y-globulin.
The finding of others (7, 8) that -ylm-proteins are more confined to the plasma compartment than are y-or ylA-globulins was confirmed.
SUM MARY
Normal y-globulin and M-component metabolism is studied in nine patients with myeloma and allied diseases. By two isotopic labels, 1125 and I131, two proteins are studied simultaneously in each patient. Because of evidence for extravascular catabolism of immune globulins in some of these patients, a new method of analysis is applied to the data. Intravascular and extravascular catabolic rates, extravascular/intravascular pool ratios, and mass turnover are calculated for 16 proteins in eight patients. The catabolic rates of the pair of proteins studied in each patient are compared statistically and are shown to be the same in most instances. A notable exception is a patient with macroglobulinemia in whom normal y-globulin is catabolized intravascularly at a normal rate, whereas the M-component is catabolized only extravascularly.
The present data support the contention that the high serum concentrations of M-components and the low serum concentrations of normal y-globulin observed commonly in these patients are secondary to high and low synthetic rates, respectively. Extravascular catabolism superimposed on essentially normal intravascular catabolism may also contribute to the low serum concentrations of normal y-globulin.
